-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Recurrence Patterns for Regionally #MetastaticMelanoma Treated in the Era of #AdjuvantTherapy : A Systematic Review and Meta-Analysis https://t.co/Rkbwi0j8KA #VisualAbstract @McMastersKelly https://t.co/X46Ix4KPEk
-
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
How Often Do #SentinelLymphNode Biopsy Results Affect #AdjuvantTherapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− #BreastCancer in the Post- #RxPONDER Era? https://t.co/KhOOj53JnF @MPilewskie @LiorBraunstein @MSKCancerCenter #VisualAbstract @McMastersKelly https://t.co/G25SbAF7r6
-
-
Mashup Score: 1Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Margin Management and #AdjuvantTherapy for #Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members @miadiegomd @UPMC @RosenbergerMd @DukeSurgOnc @kpmcguiremd @VCUMassey https://t.co/CJHrrhMbYU #VisualAbstract @McMastersKelly https://t.co/OsCPMrcl64
-
-
Mashup Score: 0Adjuvant nivolumab exhibits activity in stage II melanoma - 2 year(s) ago
Adjuvant nivolumab extended RFS compared with placebo among patients with stage IIB/stage IIC melanoma, according to topline data released by the agent’s manufacturer.Nivolumab (Opdivo, Bristol Myers Squibb), a PD-1 immune checkpoint inhibitor, is approved in the United States for several oncology indications. These apply to use of the agent by specific patients with melanoma, non-small
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#AdjuvantNivolumab exhibits activity in stage II melanoma. https://t.co/lIOnNm721P #melanoma #nivolumab #adjuvanttherapy #MedTwitter #MedEd #MedEducation #Oncology #OncAlert @bmsnews
-
-
Mashup Score: 7
As options grow, clinicians must help patients understand and weigh benefits vs risks
Source: www.medpagetoday.comCategories: Hem/Oncs, Latest HeadlinesTweet-
A brief interview on the evolving role of #AdjuvantTherapy in #KidneyCancer and #BladderCancer from our @ASCO education book @chana_weinstock @PavlosMsaouel @ScotNiglio @EliasChandran @nsimonster #blcsm #krcc https://t.co/2B44bKNc7P
-
-
Mashup Score: 0
Background Phyllodes tumors (PTs) are rare breast neoplasms with variable clinical behavior by histologic type: benign, borderline, or malignant. Until recently, management guidelines recommended one approach for all subtypes. Methods A 21-question survey was sent to American Society of Breast Surgeon members to evaluate management patterns by subtype. Surgeon demographics, decisions regarding…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Early Access From @AnnSurgOncol: Margin Management and #AdjuvantTherapy for #PhyllodesTumors: Practice Patterns of the American Society of Breast Surgeons Members. https://t.co/EE7ljE0j3I @McMastersKelly https://t.co/WWzSZqgHxK
-
-
Mashup Score: 2
Background Phyllodes tumors (PTs) are rare breast neoplasms with variable clinical behavior by histologic type: benign, borderline, or malignant. Until recently, management guidelines recommended one approach for all subtypes. Methods A 21-question survey was sent to American Society of Breast Surgeon members to evaluate management patterns by subtype. Surgeon demographics, decisions regarding…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
AHEAD OF PRINT: #MarginManagement and #AdjuvantTherapy for #PhyllodesTumors: Practice Patterns of the American Society of Breast Surgeons Members. https://t.co/a2DoYc6hdl @McMastersKelly @SocSurgOnc https://t.co/7MHnt9tTLP
-
-
Mashup Score: 1Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | NEJM - 2 year(s) ago
Original Article from The New England Journal of Medicine — Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
#CtDNA Analysis Guiding #AdjuvantTherapy in Stage II #ColonCancer: It reduces adjuvant chemo use!👇 https://t.co/UCKe6YPg6O @JeanneTie @RalphHruban https://t.co/xAmfCTG28W
-
-
Mashup Score: 0
Researchers conducted a literature search for evidence of the effects of medical marijuana products on symptom burden in patients with cancer.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Cannabis and cannabinoid products may have potential as an #adjuvanttherapy for some adult patients with cancer; however, their role in the management of cancer-related symptoms remains unclear. Presented at @oncologynursing conference #ONSCongress. https://t.co/AfGLRwyFPE
-
Disparities in Receipt of #AdjuvantTherapy After Upfront Surgical Resection for #Pancreatic Ductal #Adenocarcinoma @RoiAnteby @motazqadan @MGHSurgery @newtonwellesley https://t.co/7CWUeowndZ #VisualAbstract @McMastersKelly https://t.co/s21tDHdgWW